Rapid detection of SARS-CoV-2 variants using allele-specific PCR.

Allele-specific PCR SARS-CoV-2 Variant assay Variants of concerns Whole genome sequencing

Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
05 2022
Historique:
received: 22 11 2021
revised: 12 02 2022
accepted: 15 02 2022
pubmed: 20 2 2022
medline: 16 3 2022
entrez: 19 2 2022
Statut: ppublish

Résumé

Tracking severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants through whole genome sequencing (WGS) is vital for effective infection control and prevention (IPC) measures, but can be time-consuming and resource-heavy. We describe an in-house validation of an allele-specific polymerase chain reaction (ASP) variant assay to detect variants of concern (VOC). ASP sensitivity for detecting Delta, Alpha and Beta was 99.45 %, 100 %, and 66.67 %, respectively, compared with WGS. Specificity was 100 % in detecting all three VOC. ASP generated results 1.3 days faster compared with WGS. These findings suggest using variant assays such as ASP may enhance epidemiological surveillance and IPC measures.

Identifiants

pubmed: 35182711
pii: S0166-0934(22)00044-1
doi: 10.1016/j.jviromet.2022.114497
pmc: PMC8848537
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114497

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Références

Genome Med. 2021 Feb 9;13(1):21
pubmed: 33563320
J Clin Virol. 2021 Aug;141:104903
pubmed: 34182300
Virus Evol. 2020 Oct 05;6(2):veaa075
pubmed: 33318859
J Clin Virol. 2021 Aug;141:104877
pubmed: 34134034
J Clin Microbiol. 2021 Oct 19;59(11):e0104621
pubmed: 34379527
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
Euro Surveill. 2021 Apr;26(16):
pubmed: 33890566
J Clin Virol. 2021 Oct;143:104969
pubmed: 34509927

Auteurs

Sanjita Brito-Mutunayagam (S)

Medical Microbiology and Virology Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom. Electronic address: s.brito-mutunayagam@nhslothian.scot.nhs.uk.

Daniel Maloney (D)

Medical Microbiology and Virology Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom. Electronic address: Daniel.maloney@nhslothian.scot.nhs.uk.

Gina McAllister (G)

Medical Microbiology and Virology Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom. Electronic address: Gina.mccallister@nhslothian.scot.nhs.uk.

Rebecca Dewar (R)

Medical Microbiology and Virology Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom. Electronic address: Rebecca.dewar@nhslothian.scot.nhs.uk.

Martin McHugh (M)

Medical Microbiology and Virology Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom. Electronic address: Martin.mchugh@nhslothian.scot.nhs.uk.

Kate Templeton (K)

Medical Microbiology and Virology Service, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, United Kingdom. Electronic address: Kate.templeton@nhslothian.scot.nhs.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH